Novartis’ Ianalumab Demonstrates Potential in Phase 3 Sjögren’s Syndrome Trials
Novartis' ianalumab has shown promise in Phase 3 clinical trials for the treatment of Sjögren's…
Novartis
Novartis Trial Update: Maria Maraggeli Defends Testimony Amid Controversy
Maria Maraggeli, a key witness in the Novartis trial, insists her testimony was true despite…
Asia’s Biopharma Boom: GSK, Hengrui, Novartis, and Pfizer Lead the Charge
Major pharmaceutical companies are partnering with Asian biotechs to tap into the region's innovative pipeline…